Clinical trial
Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes
NCT00497133 · University of Copenhagen, Other · Completed
Key facts
| NCT number | NCT00497133 |
|---|---|
| Title | Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes |
| Lead sponsor | University of Copenhagen, Other |
| Collaborators | Novo Nordisk A/S Industry The Danish Diabetes Association |
| Status | Completed |
| Study type | Observational |
| Conditions | Type 2 Diabetes Mellitus |
| Enrollment | 20 |
| Start date | Jul 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jul 6, 2007 |
| Last update posted | Jun 4, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: